Company / Current Assets per Share
TG Therapeutics, Inc. Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$4.05
FY2025
5-year range
$1.17 / $4.05
FY2021-FY2025
Trend
+8.2%
vs FY2024
Sector context
#147 of 210
Health Care
What the data says
At $4.05, TG Therapeutics, Inc.'s current assets per share ranks #147 of 210 in the Health Care sector. Current Assets per Share has increased for 3 consecutive years, from $1.17 in FY2022 to $4.05 in FY2025.
Based on SEC 10-K filings.
4.05 in FY2025 with a 5-year CAGR of -6.3%.
Improved from $2.17 to $4.05 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +51.0%
- 5-Year CAGR
- -6.3%
- 10-Year CAGR
- -
Sector benchmark
#147 of 210 in Health CareTop 70% of 210This company $4.05 Sector average $170.65
▼
-97.6% below sector average
Key checks
Key Insights
- TG Therapeutics, Inc.'s current assets per share has grown for 3 consecutive years.
- In FY2025, current assets per share increased 8.2% year-over-year.
- Ranks #147 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.05 | +8.2% |
| FY2024 | $3.74 | +72.2% |
| FY2023 | $2.17 | +84.9% |
| FY2022 | $1.17 | -50.1% |
| FY2021 | $2.35 | -57.9% |
| FY2020 | $5.59 | +214.5% |
| FY2019 | $1.78 | +64.6% |
| FY2018 | $1.08 | -28.1% |
| FY2017 | $1.50 | +45.0% |
| FY2016 | $1.04 | -45.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026